| Cat. No. |
Product |
Quantity/Size |
Price |
Data |
|
| RGK11302A |
Anti-Ganglioside GD3 Antibody (R24) |
100µg |
$420.00
|
 |
BUY
|
| RGK11302B |
Anti-Ganglioside GD3 Antibody (R24) |
1mg |
$1,880.00
|
|
BUY
|
| RXX11501B |
Human Anti-Bordetella pertussis fhaB/FHA (T5) mAb |
1.0 mg |
$2,135.00
|
|
BUY
|
| RXX11501A |
Human Anti-Bordetella pertussis fhaB/FHA (T5) mAb |
100 µg |
$475.00
|
|
BUY
|
| RVV08808B |
Human Anti-HPV16 L1/Major capsid protein L1 (H16.14J) mAb |
1.0 mg |
$2,135.00
|
|
BUY
|
| RVV08808A |
Human Anti-HPV16 L1/Major capsid protein L1 (H16.14J) mAb |
100 µg |
$475.00
|
|
BUY
|
| RVV08804A |
Human Anti-HPV16 L1/Major capsid protein L1 (H16.U4) mAb |
100 µg |
$475.00
|
|
BUY
|
| RVV08804B |
Human Anti-HPV16 L1/Major capsid protein L1 (H16.U4) mAb |
1.0 mg |
$2,135.00
|
|
BUY
|
| FHF90720B |
Human Anti-Human ROR1 (P3A1) mAb |
100 ug |
$430.00
|
|
BUY
|
| FHF90720C |
Human Anti-Human ROR1 (P3A1) mAb |
1.0 mg |
$1,565.00
|
|
BUY
|
| FHF90720A |
Human Anti-Human ROR1 (P3A1) mAb |
50 ug |
$300.00
|
|
BUY
|
| FHF90722A |
Human Anti-Human ROR1 (P3A1) mAb, PE |
50 tests |
$375.00
|
|
BUY
|
| FHF90722B |
Human Anti-Human ROR1 (P3A1) mAb, PE |
100 tests |
$550.00
|
|
BUY
|
| FHF90710B |
Human Anti-Human ROR1 (SAA0140) mAb |
100 ug |
$430.00
|
|
BUY
|
| FHF90710C |
Human Anti-Human ROR1 (SAA0140) mAb |
1.0 mg |
$1,565.00
|
|
BUY
|
| FHF90710A |
Human Anti-Human ROR1 (SAA0140) mAb |
50 ug |
$300.00
|
|
BUY
|
| CPC538B |
Human Anti-SARS-CoV-2 (2019-nCoV) Spike Glycoprotein Sotrovimab (VIR-7831 / GSK4182136) Neutralizing mAb |
100 µg |
Please Inquire |
|
BUY
|
| CPC538A |
Human Anti-SARS-CoV-2 (2019-nCoV) Spike Glycoprotein Sotrovimab (VIR-7831 / GSK4182136) Neutralizing mAb |
50 µg |
Please Inquire |
|
BUY
|
| CPC524B |
Human Anti-SARS-CoV-2 (2019-nCoV) Spike S1 Neutralizing mAb |
100 µg |
Please Inquire |
|
BUY
|
| CPC524A |
Human Anti-SARS-CoV-2 (2019-nCoV) Spike S1 Neutralizing mAb |
50 µg |
Please Inquire |
|
BUY
|
| CPC530A |
Human Anti-SARS-CoV-2 (2019-nCoV) Spike S2, Clone AbF712, mAb |
50 µg |
Please Inquire |
|
BUY
|
| CPC530B |
Human Anti-SARS-CoV-2 (2019-nCoV) Spike S2, Clone AbF712, mAb |
100 µg |
Please Inquire |
|
BUY
|
| CPC531A |
Human Anti-SARS-CoV-2 (2019-nCoV) Spike S2, Clone AbH722, mAb |
50 µg |
Please Inquire |
|
BUY
|
| CPC531B |
Human Anti-SARS-CoV-2 (2019-nCoV) Spike S2, Clone AbH722, mAb |
100 µg |
Please Inquire |
|
BUY
|
| CPC537B |
Human Anti-SARS-CoV-2 (2019-nCoV) Spike-RBD Tixagevimab (AZD8895) Neutralizing mAb |
100 µg |
Please Inquire |
|
BUY
|
| CPC537A |
Human Anti-SARS-CoV-2 (2019-nCoV) Spike-RBD Tixagevimab (AZD8895) Neutralizing mAb |
50 µg |
Please Inquire |
|
BUY
|
| CPC517B |
Human Anti-SARS-CoV-2 Nucleocapsid (AbD207) mAb |
100 µg |
Please Inquire |
|
BUY
|
| CPC517A |
Human Anti-SARS-CoV-2 Nucleocapsid (AbD207) mAb |
50 µg |
Please Inquire |
|
BUY
|
| CPC518B |
Human Anti-SARS-CoV-2 Nucleocapsid (AbG733) mAb |
100 µg |
Please Inquire |
|
BUY
|
| CPC518A |
Human Anti-SARS-CoV-2 Nucleocapsid (AbG733) mAb |
50 µg |
Please Inquire |
|
BUY
|
| CPC522A |
Human Anti-SARS-CoV-2 Spike RBD (B38) Neutralizing mAb |
50 µg |
Please Inquire |
|
BUY
|
| CPC523B |
Human Anti-SARS-CoV-2 Spike RBD (B38) Neutralizing mAb |
100 µg |
Please Inquire |
|
BUY
|
| CPC522B |
Human Anti-SARS-CoV-2 Spike RBD (B38) Neutralizing mAb |
100 µg |
Please Inquire |
|
BUY
|
| CPC523A |
Human Anti-SARS-CoV-2 Spike RBD (B38) Neutralizing mAb |
50 µg |
Please Inquire |
|
BUY
|
| CPC521A |
Human Anti-SARS-CoV-2 Spike RBD (H4) Neutralizing mAb |
50 µg |
Please Inquire |
|
BUY
|
| CPC521B |
Human Anti-SARS-CoV-2 Spike RBD (H4) Neutralizing mAb |
100 µg |
Please Inquire |
|
BUY
|
| CPC520A |
Human Anti-SARS-CoV-2 Spike S1 (CR3022) Neutralizing mAb |
50 µg |
Please Inquire |
|
BUY
|
| CPC520B |
Human Anti-SARS-CoV-2 Spike S1 (CR3022) Neutralizing mAb |
100 µg |
Please Inquire |
|
BUY
|
| CPC542C |
Human Anti-SARS-CoV-2 Spike-RBD (002-S21F2) Broad-Neutralizing mAb |
1.0 mg |
Please Inquire |
|
BUY
|
| CPC526A |
Human Anti-SARS-CoV-2 Spike-RBD (Clone AbG123) Neutralizing mAb |
50 µg |
Please Inquire |
|
BUY
|
| CPC526B |
Human Anti-SARS-CoV-2 Spike-RBD (Clone AbG123) Neutralizing mAb |
100 µg |
Please Inquire |
|
BUY
|
| CPC513A |
Human Anti-SARS-CoV-2 Spike-RBD (EY6A) Neutralizing mAb |
50 µg |
Please Inquire |
|
BUY
|
| CPC513B |
Human Anti-SARS-CoV-2 Spike-RBD (EY6A) Neutralizing mAb |
100 µg |
Please Inquire |
|
BUY
|
| CPC525B |
Human Anti-SARS-CoV-2 Spike-RBD (S309) Neutralizing mAb |
100 µg |
Please Inquire |
|
BUY
|
| CPC525A |
Human Anti-SARS-CoV-2 Spike-RBD (S309) Neutralizing mAb |
50 µg |
Please Inquire |
|
BUY
|
| CPC539C |
Human Anti-SARS-CoV-2 Spike-RBD Bebtelovimab (LY-CoV1404 / LY3853113) Neutralizing mAb |
1.0 mg |
Please Inquire |
|
BUY
|
| CPC539A |
Human Anti-SARS-CoV-2 Spike-RBD Bebtelovimab (LY-CoV1404 / LY3853113) Neutralizing mAb |
50 µg |
Please Inquire |
|
BUY
|
| CPC539B |
Human Anti-SARS-CoV-2 Spike-RBD Bebtelovimab (LY-CoV1404 / LY3853113) Neutralizing mAb |
100 µg |
Please Inquire |
|
BUY
|
| CPC516A |
Human Anti-SARS-CoV-2 Spike-RBD Etesevimab (CB6, JS016, LY-CoV-016) Neutralizing mAb |
50 µg |
Please Inquire |
|
BUY
|
| CPC516B |
Human Anti-SARS-CoV-2 Spike-RBD Etesevimab (CB6, JS016, LY-CoV-016) Neutralizing mAb |
100 µg |
Please Inquire |
|
BUY
|
| CPC541B |
Human Anti-SARS-CoV-2 Spike-RBD Neutralizing (S2E12) mAb |
100 µg |
Please Inquire |
|
BUY
|
| CPC541C |
Human Anti-SARS-CoV-2 Spike-RBD Neutralizing (S2E12) mAb |
1.0 mg |
Please Inquire |
|
BUY
|
| CPC541A |
Human Anti-SARS-CoV-2 Spike-RBD Neutralizing (S2E12) mAb |
50 µg |
Please Inquire |
|
BUY
|
| DHC21902A |
Research Grade Etaracizumab |
100 ug |
$380.00
|
|
BUY
|
| DHC21902B |
Research Grade Etaracizumab |
1.0 mg |
$1,380.00
|
|
BUY
|
| DHC31201A |
Research Grade 4F2Mab |
100 ug |
$380.00
|
|
BUY
|
| DHC31201B |
Research Grade 4F2Mab |
1.0 mg |
$1,380.00
|
|
BUY
|
| DHC21901A |
Research Grade Abituzumab |
100 ug |
$380.00
|
|
BUY
|
| DHC21901B |
Research Grade Abituzumab |
1.0 mg |
$1,380.00
|
|
BUY
|
| DHC98804B |
Research Grade Abrilumab |
1.0 mg |
$1,380.00
|
|
BUY
|
| DHC98804A |
Research Grade Abrilumab |
100 ug |
$380.00
|
|
BUY
|
| DHE16603B |
Research Grade Alacizumab |
1.0 mg |
$1,380.00
|
|
BUY
|
| DHE16603A |
Research Grade Alacizumab |
100 ug |
$380.00
|
|
BUY
|
| DHG52001B |
Research Grade Anetumab
|
1.0 mg |
$1,520.00
|
|
BUY
|
| DHG52001A |
Research Grade Anetumab
|
100 ug |
$420.00
|
|
BUY
|
| DHK11301B |
Research Grade Anti-Ganglioside GD3 (PF-06688992) |
1mg |
$1,705.00
|
|
BUY
|
| DHK11301A |
Research Grade Anti-Ganglioside GD3 (PF-06688992) |
100µg |
$460.00
|
|
BUY
|
| DHK33901A |
Research Grade Anti-Human CA19-9/Sialyl Lewis A (sLe A) Antibody (MVT-5873) |
100µg |
$460.00
|
|
BUY
|
| DHK33901B |
Research Grade Anti-Human CA19-9/Sialyl Lewis A (sLe A) Antibody (MVT-5873) |
1mg |
$1,705.00
|
|
BUY
|
| DHD34004B |
Research Grade Anti-Human CD120a/TNFRSF1A/TNFR1 (GSK2862277) |
1.0 mg |
$1,380.00
|
|
BUY
|
| DHD34004A |
Research Grade Anti-Human CD120a/TNFRSF1A/TNFR1 (GSK2862277) |
100 µg |
$380.00
|
|
BUY
|
| DHG11010A |
Research Grade Anti-Human CD137/TNFRSF9/4-1BB (AGEN 2373) |
100 ug |
$475.00
|
|
BUY
|
| DHG11010B |
Research Grade Anti-Human CD137/TNFRSF9/4-1BB (AGEN 2373) |
1.0 mg |
$1,715.00
|
|
BUY
|
| DHF68802A |
Research Grade Anti-Human CD156b/ADAM17 (D8P1C1) |
100 ug |
$475.00
|
|
BUY
|
| DHF68802B |
Research Grade Anti-Human CD156b/ADAM17 (D8P1C1) |
1.0 mg |
$1,715.00
|
|
BUY
|
| DHF68801A |
Research Grade Anti-Human CD156b/ADAM17 (MEDI3622) |
100 ug |
$475.00
|
|
BUY
|
| DHF68801B |
Research Grade Anti-Human CD156b/ADAM17 (MEDI3622) |
1.0 mg |
$1,715.00
|
|
BUY
|
| DHF64006A |
Research Grade Anti-Human CD172a/SIRPA (CC-95251) |
100 µg |
$420.00
|
|
BUY
|
| DHF64006B |
Research Grade Anti-Human CD172a/SIRPA (CC-95251) |
1.0 mg |
$1,520.00
|
|
BUY
|
| DHJ14403B |
Research Grade Anti-Human CD272/BTLA (ANB032) |
1.0 mg |
$1,715.00
|
|
BUY
|
| DHJ14403A |
Research Grade Anti-Human CD272/BTLA (ANB032) |
100 µg |
$475.00
|
|
BUY
|
| DHJ89810A |
Research Grade Anti-Human CD357/TNFRSF18/GITR (REGN 6569) |
100 ug |
$475.00
|
|
BUY
|
| DHJ89810B |
Research Grade Anti-Human CD357/TNFRSF18/GITR (REGN 6569) |
100 ug |
$1,715.00
|
|
BUY
|
| DHE25604B |
Research Grade Anti-Human CD66c/CEACAM6 (NOV1803) mAb |
1.0 mg |
$2,410.00
|
|
BUY
|
| DHE25604A |
Research Grade Anti-Human CD66c/CEACAM6 (NOV1803) mAb |
100 ug |
$640.00
|
|
BUY
|
| DHD48801B |
Research Grade Anti-Human CD9 (AT14-012) |
1.0 mg |
$1,715.00
|
|
BUY
|
| DHD48801A |
Research Grade Anti-Human CD9 (AT14-012) |
100 ug |
$475.00
|
|
BUY
|
| DHE25701A |
Research Grade Anti-Human CD96 (GSK6097608) mAb |
100 µg |
$475.00
|
|
BUY
|
| DHE25701B |
Research Grade Anti-Human CD96 (GSK6097608) mAb |
1.0 mg |
$1,715.00
|
|
BUY
|
| DHJ05001A |
Research Grade Anti-Human IL31 (BMS-981164) |
100 ug |
$475.00
|
|
BUY
|
| DHJ05001B |
Research Grade Anti-Human IL31 (BMS-981164) |
1.0 mg |
$1,715.00
|
|
BUY
|
| DHK11102B |
Research Grade Anti-Human Lewis Y (MB 311) |
1mg |
$1,505.00
|
|
BUY
|
| DHK11102A |
Research Grade Anti-Human Lewis Y (MB 311) |
100µg |
$405.00
|
|
BUY
|
| DHK11101A |
Research Grade Anti-Human Lewis Y (MB 314) |
100µg |
$405.00
|
|
BUY
|
| DHK11101B |
Research Grade Anti-Human Lewis Y (MB 314) |
1mg |
$1,505.00
|
|
BUY
|
| DHK11103A |
Research Grade Anti-Human Lewis Y/Le(y) Antibody (hu3S193) |
100µg |
$460.00
|
|
BUY
|
| DHK11103B |
Research Grade Anti-Human Lewis Y/Le(y) Antibody (hu3S193) |
1mg |
$1,705.00
|
|
BUY
|
| DHD00501B |
Research Grade Anti-Human OSM/Oncostatin-M (GSK2330811) |
1.0 mg |
$1,715.00
|
|
BUY
|
| DHD00501A |
Research Grade Anti-Human OSM/Oncostatin-M (GSK2330811) |
100 ug |
$475.00
|
|
BUY
|
| DHD00502B |
Research Grade Anti-Human OSM/Oncostatin-M (GSK315234) |
1.0 mg |
$1,715.00
|
|
BUY
|
